Brief: Icosavax Reports Fourth Quarter And Full Year 2022 Financial Results And Provides Corporate Update

Icosavax

30/03/2023 21:36

March 30 (Reuters) - Icosavax Inc  ICVX.O :
    * ICOSAVAX REPORTS FOURTH QUARTER AND FULL YEAR 2022
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
    * ICOSAVAX INC - CASH AND CASH EQUIVALENTS, RESTRICTED CASH,
AND
SHORT-TERM INVESTMENTS OF $219.4 MILLION AT END 4Q 2022
    * ICOSAVAX INC - COMPLETED DOSING IN ONGOING PHASE 1 STUDY
OF
IVX-A12; TOPLINE INTERIM RESULTS EXPECTED IN 2Q 2023
    * ICOSAVAX INC - CURRENTLY EXPECTS ITS CASH BALANCE TO BE
SUFFICIENT TO FUND OPERATIONS THROUGH AT LEAST 2024
    * ICOSAVAX INC- QTRLY LOSS PER SHARE $0.59

Source text for Eikon:  ID:nGNX4XzCX7 
Further company coverage:  ICVX.O 

 ((Reuters.Briefs@thomsonreuters.com;;))